The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10187 malaria professionals are enjoying the free benefits of MalariaWorld today

G6PD deficiency

Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia

October 8, 2019 - 14:57 -- Open Access
Author(s): 
Eugenia Lo, Daibin Zhong, Beka Raya, Kareen Pestana, Cristian Koepfli, Ming-Chieh Lee, Delenasaw Yewhalaw and Guiyun Yan
Reference: 
Malaria Journal 2019 18:340, 7 October 2019

G6PD enzyme deficiency is a common enzymatic X-linked disorder. Deficiency of the G6PD enzyme can cause free radical-mediated oxidative damage to red blood cells, leading to premature haemolysis. Treatment of Plasmodium vivax malaria with primaquine poses a potential risk of mild to severe acute haemolytic anaemia in G6PD deficient people. In this study, the prevalence and distribution of G6PD mutations were investigated across broad areas of Ethiopia, and tested the association between G6PD genotype and phenotype with the goal to provide additional information relevant to the use of primaquine in malaria treatment.

Country: 
Subscribe to RSS - G6PD deficiency